
Loratadine Tablets Industry Research Report 2025
Description
Summary
According to APO Research, the global Loratadine Tablets market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Loratadine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Loratadine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Loratadine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Loratadine Tablets include Anhui Guosen Pharmaceutical Co., Ltd., Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd., Guangdong Hengcheng Pharmaceutical Co., Ltd., Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd., Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd., Heilongjiang Nuojie Pharmaceutical Co., Ltd., Hubei Minkang Pharmaceutical Co., Ltd., Hunan Erkang Pharmaceutical Co., Ltd. and Hunan Zhongnan Pharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Loratadine Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Loratadine Tablets.
The report will help the Loratadine Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Loratadine Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Loratadine Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Loratadine Tablets Segment by Company
Anhui Guosen Pharmaceutical Co., Ltd.
Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd.
Guangdong Hengcheng Pharmaceutical Co., Ltd.
Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.
Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
Heilongjiang Nuojie Pharmaceutical Co., Ltd.
Hubei Minkang Pharmaceutical Co., Ltd.
Hunan Erkang Pharmaceutical Co., Ltd.
Hunan Zhongnan Pharmaceutical Co., Ltd.
Jilin Jinheng Pharmaceutical Co., Ltd.
Sancai Shiqi Pharmaceutical Co., Ltd.
Shanxi Qianyuan Pharmaceutical Group Co., Ltd.
Shanxi Xinyu Pharmaceutical Co., Ltd.
Sichuan Deyuan Pharmaceutical Group Co., Ltd.
Sichuan Shenghe Pharmaceutical Co., Ltd.
Tonghua Great Wall Pharmaceutical Co., Ltd.
Yabao Pharmaceutical Group Co., Ltd.
Yunnan Longfa Pharmaceutical Co., Ltd.
Yunpeng Pharmaceutical Group Co., Ltd.
Zhejiang Ruixin Pharmaceutical Co., Ltd.
Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
Loratadine Tablets Segment by Type
20 mg/Tablet
40 mg/Tablet
60 mg/Tablet
Loratadine Tablets Segment by Application
Hospital
Pharmacy
Online e-commerce
Other
Loratadine Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Loratadine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Loratadine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Loratadine Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Loratadine Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Loratadine Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Loratadine Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, the global Loratadine Tablets market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Loratadine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Loratadine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Loratadine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Loratadine Tablets include Anhui Guosen Pharmaceutical Co., Ltd., Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd., Guangdong Hengcheng Pharmaceutical Co., Ltd., Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd., Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd., Heilongjiang Nuojie Pharmaceutical Co., Ltd., Hubei Minkang Pharmaceutical Co., Ltd., Hunan Erkang Pharmaceutical Co., Ltd. and Hunan Zhongnan Pharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Loratadine Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Loratadine Tablets.
The report will help the Loratadine Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Loratadine Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Loratadine Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Loratadine Tablets Segment by Company
Anhui Guosen Pharmaceutical Co., Ltd.
Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd.
Guangdong Hengcheng Pharmaceutical Co., Ltd.
Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.
Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
Heilongjiang Nuojie Pharmaceutical Co., Ltd.
Hubei Minkang Pharmaceutical Co., Ltd.
Hunan Erkang Pharmaceutical Co., Ltd.
Hunan Zhongnan Pharmaceutical Co., Ltd.
Jilin Jinheng Pharmaceutical Co., Ltd.
Sancai Shiqi Pharmaceutical Co., Ltd.
Shanxi Qianyuan Pharmaceutical Group Co., Ltd.
Shanxi Xinyu Pharmaceutical Co., Ltd.
Sichuan Deyuan Pharmaceutical Group Co., Ltd.
Sichuan Shenghe Pharmaceutical Co., Ltd.
Tonghua Great Wall Pharmaceutical Co., Ltd.
Yabao Pharmaceutical Group Co., Ltd.
Yunnan Longfa Pharmaceutical Co., Ltd.
Yunpeng Pharmaceutical Group Co., Ltd.
Zhejiang Ruixin Pharmaceutical Co., Ltd.
Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
Loratadine Tablets Segment by Type
20 mg/Tablet
40 mg/Tablet
60 mg/Tablet
Loratadine Tablets Segment by Application
Hospital
Pharmacy
Online e-commerce
Other
Loratadine Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Loratadine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Loratadine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Loratadine Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Loratadine Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Loratadine Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Loratadine Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
144 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Loratadine Tablets Market Size (2020-2031)
- 2.2.2 Global Loratadine Tablets Sales (2020-2031)
- 2.2.3 Global Loratadine Tablets Market Average Price (2020-2031)
- 2.3 Loratadine Tablets by Type
- 2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- 2.3.2 20 mg/Tablet
- 2.3.3 40 mg/Tablet
- 2.3.4 60 mg/Tablet
- 2.4 Loratadine Tablets by Application
- 2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
- 2.4.2 Hospital
- 2.4.3 Pharmacy
- 2.4.4 Online e-commerce
- 2.4.5 Other
- 3 Market Competitive Landscape by Manufacturers
- 3.1 Global Loratadine Tablets Market Competitive Situation by Manufacturers (2020 Versus 2024)
- 3.2 Global Loratadine Tablets Sales (K Units) of Manufacturers (2020-2025)
- 3.3 Global Loratadine Tablets Revenue of Manufacturers (2020-2025)
- 3.4 Global Loratadine Tablets Average Price by Manufacturers (2020-2025)
- 3.5 Global Loratadine Tablets Industry Ranking, 2023 VS 2024 VS 2025
- 3.6 Global Manufacturers of Loratadine Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Loratadine Tablets, Product Type & Application
- 3.8 Global Manufacturers of Loratadine Tablets, Established Date
- 3.9 Global Loratadine Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
- 4 Manufacturers Profiled
- 4.1 Anhui Guosen Pharmaceutical Co., Ltd.
- 4.1.1 Anhui Guosen Pharmaceutical Co., Ltd. Company Information
- 4.1.2 Anhui Guosen Pharmaceutical Co., Ltd. Business Overview
- 4.1.3 Anhui Guosen Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
- 4.1.4 Anhui Guosen Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 4.1.5 Anhui Guosen Pharmaceutical Co., Ltd. Recent Developments
- 4.2 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd.
- 4.2.1 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Company Information
- 4.2.2 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Business Overview
- 4.2.3 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
- 4.2.4 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 4.2.5 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Recent Developments
- 4.3 Guangdong Hengcheng Pharmaceutical Co., Ltd.
- 4.3.1 Guangdong Hengcheng Pharmaceutical Co., Ltd. Company Information
- 4.3.2 Guangdong Hengcheng Pharmaceutical Co., Ltd. Business Overview
- 4.3.3 Guangdong Hengcheng Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
- 4.3.4 Guangdong Hengcheng Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 4.3.5 Guangdong Hengcheng Pharmaceutical Co., Ltd. Recent Developments
- 4.4 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.
- 4.4.1 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Company Information
- 4.4.2 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Business Overview
- 4.4.3 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
- 4.4.4 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Portfolio
- 4.4.5 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Recent Developments
- 4.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
- 4.5.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Company Information
- 4.5.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Business Overview
- 4.5.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
- 4.5.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 4.5.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Recent Developments
- 4.6 Heilongjiang Nuojie Pharmaceutical Co., Ltd.
- 4.6.1 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Company Information
- 4.6.2 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Business Overview
- 4.6.3 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
- 4.6.4 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 4.6.5 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Recent Developments
- 4.7 Hubei Minkang Pharmaceutical Co., Ltd.
- 4.7.1 Hubei Minkang Pharmaceutical Co., Ltd. Company Information
- 4.7.2 Hubei Minkang Pharmaceutical Co., Ltd. Business Overview
- 4.7.3 Hubei Minkang Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
- 4.7.4 Hubei Minkang Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 4.7.5 Hubei Minkang Pharmaceutical Co., Ltd. Recent Developments
- 4.8 Hunan Erkang Pharmaceutical Co., Ltd.
- 4.8.1 Hunan Erkang Pharmaceutical Co., Ltd. Company Information
- 4.8.2 Hunan Erkang Pharmaceutical Co., Ltd. Business Overview
- 4.8.3 Hunan Erkang Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
- 4.8.4 Hunan Erkang Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 4.8.5 Hunan Erkang Pharmaceutical Co., Ltd. Recent Developments
- 4.9 Hunan Zhongnan Pharmaceutical Co., Ltd.
- 4.9.1 Hunan Zhongnan Pharmaceutical Co., Ltd. Company Information
- 4.9.2 Hunan Zhongnan Pharmaceutical Co., Ltd. Business Overview
- 4.9.3 Hunan Zhongnan Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
- 4.9.4 Hunan Zhongnan Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 4.9.5 Hunan Zhongnan Pharmaceutical Co., Ltd. Recent Developments
- 4.10 Jilin Jinheng Pharmaceutical Co., Ltd.
- 4.10.1 Jilin Jinheng Pharmaceutical Co., Ltd. Company Information
- 4.10.2 Jilin Jinheng Pharmaceutical Co., Ltd. Business Overview
- 4.10.3 Jilin Jinheng Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
- 4.10.4 Jilin Jinheng Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 4.10.5 Jilin Jinheng Pharmaceutical Co., Ltd. Recent Developments
- 4.11 Sancai Shiqi Pharmaceutical Co., Ltd.
- 4.11.1 Sancai Shiqi Pharmaceutical Co., Ltd. Company Information
- 4.11.2 Sancai Shiqi Pharmaceutical Co., Ltd. Business Overview
- 4.11.3 Sancai Shiqi Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
- 4.11.4 Sancai Shiqi Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 4.11.5 Sancai Shiqi Pharmaceutical Co., Ltd. Recent Developments
- 4.12 Shanxi Qianyuan Pharmaceutical Group Co., Ltd.
- 4.12.1 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Company Information
- 4.12.2 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Business Overview
- 4.12.3 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
- 4.12.4 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Portfolio
- 4.12.5 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Recent Developments
- 4.13 Shanxi Xinyu Pharmaceutical Co., Ltd.
- 4.13.1 Shanxi Xinyu Pharmaceutical Co., Ltd. Company Information
- 4.13.2 Shanxi Xinyu Pharmaceutical Co., Ltd. Business Overview
- 4.13.3 Shanxi Xinyu Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
- 4.13.4 Shanxi Xinyu Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 4.13.5 Shanxi Xinyu Pharmaceutical Co., Ltd. Recent Developments
- 4.14 Sichuan Deyuan Pharmaceutical Group Co., Ltd.
- 4.14.1 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Company Information
- 4.14.2 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Business Overview
- 4.14.3 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
- 4.14.4 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Portfolio
- 4.14.5 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Recent Developments
- 4.15 Sichuan Shenghe Pharmaceutical Co., Ltd.
- 4.15.1 Sichuan Shenghe Pharmaceutical Co., Ltd. Company Information
- 4.15.2 Sichuan Shenghe Pharmaceutical Co., Ltd. Business Overview
- 4.15.3 Sichuan Shenghe Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
- 4.15.4 Sichuan Shenghe Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 4.15.5 Sichuan Shenghe Pharmaceutical Co., Ltd. Recent Developments
- 4.16 Tonghua Great Wall Pharmaceutical Co., Ltd.
- 4.16.1 Tonghua Great Wall Pharmaceutical Co., Ltd. Company Information
- 4.16.2 Tonghua Great Wall Pharmaceutical Co., Ltd. Business Overview
- 4.16.3 Tonghua Great Wall Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
- 4.16.4 Tonghua Great Wall Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 4.16.5 Tonghua Great Wall Pharmaceutical Co., Ltd. Recent Developments
- 4.17 Yabao Pharmaceutical Group Co., Ltd.
- 4.17.1 Yabao Pharmaceutical Group Co., Ltd. Company Information
- 4.17.2 Yabao Pharmaceutical Group Co., Ltd. Business Overview
- 4.17.3 Yabao Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
- 4.17.4 Yabao Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Portfolio
- 4.17.5 Yabao Pharmaceutical Group Co., Ltd. Recent Developments
- 4.18 Yunnan Longfa Pharmaceutical Co., Ltd.
- 4.18.1 Yunnan Longfa Pharmaceutical Co., Ltd. Company Information
- 4.18.2 Yunnan Longfa Pharmaceutical Co., Ltd. Business Overview
- 4.18.3 Yunnan Longfa Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
- 4.18.4 Yunnan Longfa Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 4.18.5 Yunnan Longfa Pharmaceutical Co., Ltd. Recent Developments
- 4.19 Yunpeng Pharmaceutical Group Co., Ltd.
- 4.19.1 Yunpeng Pharmaceutical Group Co., Ltd. Company Information
- 4.19.2 Yunpeng Pharmaceutical Group Co., Ltd. Business Overview
- 4.19.3 Yunpeng Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
- 4.19.4 Yunpeng Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Portfolio
- 4.19.5 Yunpeng Pharmaceutical Group Co., Ltd. Recent Developments
- 4.20 Zhejiang Ruixin Pharmaceutical Co., Ltd.
- 4.20.1 Zhejiang Ruixin Pharmaceutical Co., Ltd. Company Information
- 4.20.2 Zhejiang Ruixin Pharmaceutical Co., Ltd. Business Overview
- 4.20.3 Zhejiang Ruixin Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
- 4.20.4 Zhejiang Ruixin Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 4.20.5 Zhejiang Ruixin Pharmaceutical Co., Ltd. Recent Developments
- 4.21 Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
- 4.21.1 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Company Information
- 4.21.2 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Business Overview
- 4.21.3 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
- 4.21.4 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 4.21.5 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Recent Developments
- 5 Global Loratadine Tablets Market Scenario by Region
- 5.1 Global Loratadine Tablets Market Size by Region: 2020 VS 2024 VS 2031
- 5.2 Global Loratadine Tablets Sales by Region: 2020-2031
- 5.2.1 Global Loratadine Tablets Sales by Region: 2020-2025
- 5.2.2 Global Loratadine Tablets Sales by Region: 2026-2031
- 5.3 Global Loratadine Tablets Revenue by Region: 2020-2031
- 5.3.1 Global Loratadine Tablets Revenue by Region: 2020-2025
- 5.3.2 Global Loratadine Tablets Revenue by Region: 2026-2031
- 5.4 North America Loratadine Tablets Market Facts & Figures by Country
- 5.4.1 North America Loratadine Tablets Market Size by Country: 2020 VS 2024 VS 2031
- 5.4.2 North America Loratadine Tablets Sales by Country (2020-2031)
- 5.4.3 North America Loratadine Tablets Revenue by Country (2020-2031)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Loratadine Tablets Market Facts & Figures by Country
- 5.5.1 Europe Loratadine Tablets Market Size by Country: 2020 VS 2024 VS 2031
- 5.5.2 Europe Loratadine Tablets Sales by Country (2020-2031)
- 5.5.3 Europe Loratadine Tablets Revenue by Country (2020-2031)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Loratadine Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Loratadine Tablets Market Size by Country: 2020 VS 2024 VS 2031
- 5.6.2 Asia Pacific Loratadine Tablets Sales by Country (2020-2031)
- 5.6.3 Asia Pacific Loratadine Tablets Revenue by Country (2020-2031)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Loratadine Tablets Market Facts & Figures by Country
- 5.7.1 South America Loratadine Tablets Market Size by Country: 2020 VS 2024 VS 2031
- 5.7.2 South America Loratadine Tablets Sales by Country (2020-2031)
- 5.7.3 South America Loratadine Tablets Revenue by Country (2020-2031)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Loratadine Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Loratadine Tablets Market Size by Country: 2020 VS 2024 VS 2031
- 5.8.2 Middle East and Africa Loratadine Tablets Sales by Country (2020-2031)
- 5.8.3 Middle East and Africa Loratadine Tablets Revenue by Country (2020-2031)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
- 6 Segment by Type
- 6.1 Global Loratadine Tablets Sales by Type (2020-2031)
- 6.1.1 Global Loratadine Tablets Sales by Type (2020-2031) & (K Units)
- 6.1.2 Global Loratadine Tablets Sales Market Share by Type (2020-2031)
- 6.2 Global Loratadine Tablets Revenue by Type (2020-2031)
- 6.2.1 Global Loratadine Tablets Sales by Type (2020-2031) & (US$ Million)
- 6.2.2 Global Loratadine Tablets Revenue Market Share by Type (2020-2031)
- 6.3 Global Loratadine Tablets Price by Type (2020-2031)
- 7 Segment by Application
- 7.1 Global Loratadine Tablets Sales by Application (2020-2031)
- 7.1.1 Global Loratadine Tablets Sales by Application (2020-2031) & (K Units)
- 7.1.2 Global Loratadine Tablets Sales Market Share by Application (2020-2031)
- 7.2 Global Loratadine Tablets Revenue by Application (2020-2031)
- 7.2.1 Global Loratadine Tablets Sales by Application (2020-2031) & (US$ Million)
- 7.2.2 Global Loratadine Tablets Revenue Market Share by Application (2020-2031)
- 7.3 Global Loratadine Tablets Price by Application (2020-2031)
- 8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Loratadine Tablets Value Chain Analysis
- 8.1.1 Loratadine Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Loratadine Tablets Production Mode & Process
- 8.2 Loratadine Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Loratadine Tablets Distributors
- 8.2.3 Loratadine Tablets Customers
- 9 Global Loratadine Tablets Analyzing Market Dynamics
- 9.1 Loratadine Tablets Industry Trends
- 9.2 Loratadine Tablets Industry Drivers
- 9.3 Loratadine Tablets Industry Opportunities and Challenges
- 9.4 Loratadine Tablets Industry Restraints
- 10 Report Conclusion
- 11 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.